PTEN is a tumor suppression gene and loss of its function results in activation of the PI3K/AKT/mTOR pathway, which has been found to be associated with adverse oncological outcomes in patients with PCa [5]. The gene discussed is MTOR; the disease is posterior cortical atrophy.